Loading company…
ViewRay developed MRI-guided radiation therapy systems for cancer treatment.
ViewRay developed the MRIdian A3i system, which uses MRI imaging and real-time tissue tracking to guide radiation treatment. Founded in 2004 in the US, the company went public through a reverse merger in July 2015 and raised USD 26.70 mn in a private placement. The company reported USD 102.21 mn in revenue and USD -101.28 mn EBITDA in 2022.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in